Watch URGN. Know when insiders buy.
One email the day a filing lands. Free.
URGN
UroGen Pharma Ltd.
34.51
−0.97 −2.73%
USD · close Oct 22
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
15
FLAG · insiders 25, shorts 5
Insiders, 90 days
−$3M
net selling · 0 buys, 4 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.7BP/E —DIV YIELD —FCF YIELD -9.43%REV TTM $188.7M +100.3%NET INCOME −$97.6MNET DEBT $120.9M52W 17.00 – 50.29NEXT EARNINGS Nov 5 EST.SEC XBRL · TTM TO Invalid Date
Insider trading
−$3M
Net, 90 days
0 / 4
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 8 | Oct 9 | Degnan Chris · Chief Financial Officer | Sell | 2,202 | $36.69 | $81K |
| Sep 8 | Sep 9 | Smith Jason Drew · General Counsel | Sell | 1,519 | $42.54 | $65K |
| Sep 8 | Sep 9 | Schoenberg Mark · Chief Medical Officer | Sell | 871 | $42.92 | $37K |
| Aug 20 | Aug 24 | Schoenberg Mark · Chief Medical Officer | Sell | 60,677 | $47.05 | $2.9M |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.